Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $466.70. The company's market cap stands at 252.13B, with a P/E ratio of 28.95 and a dividend yield of 2.13%.
On 2026-11-01, Amgen(AMGN) stock moved within a range of $465.33 to $475.65. With shares now at $466.70, the stock is trading +0.3% above its intraday low and -1.9% below the session's peak.
Trading activity shows a volume of 3.19M, compared to an average daily volume of 2.57M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $475.65 and a low of $288.00.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $475.65 and a low of $288.00.
AMGN News
Amgen reported in late October 2026 that Phase 3 data for IMDELLTRA in extensive stage small cell lung cancer and Tezspire in eosinophilic esophagitis showed st...
Investment styles come in various shapes and sizes. Some focus on growth, others seek regular income through dividends, and others are after stability. The choi...
has delivered a powerful share price run in recent years, yet the question for investors today is whether that higher tag is properly underpinned by the cash th...
Analyst ratings
51%
of 37 ratingsMore AMGN News
Collecting four figures a month from dividends without ever selling a share sounds straightforward until you price out what it actually costs and see which comp...
Investing Amgen Braces for Rising Expenses Ahead of Q3 Results—Is a Profit Squeeze Looming? Amgen (NASDAQ:AMGN | AMGN Price Prediction) is expected to report th...
Amgen (AMGN Quick QuoteAMGN - Free Report) is scheduled to report third-quarter 2026 results on Nov. 3, after market close. In the last reported quarter,...
Amgen (NasdaqGS:AMGN) reported positive Phase 3 OASIZ-301 trial results for dazodalibep in Sjögren's disease, showing reduced disease activity. At ACR Converge...
The US FDA issued Amgen (AMGN) a warning letter over a TV ad for its colorectal cancer treatment Vectibix (panitumumab), with the agency saying that it "creates...
The pharmaceutical industry is evolving rapidly, leaving many investors to wonder whether established giants can sustain their momentum. Choosing between Amgen...
Amgen Inc. (NASDAQ:AMGN) on Saturday released interim Phase 3 trial results showing that Imdelltra, evaluated in combination with AstraZeneca Plc’s (NYSE:AZN) I...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.